Successful bone reconstruction after bortezomib therapy in a myeloma patient.
作者信息
Tanaka Takayuki, Yamasaki Ryoko, Omura Hiromi, Hino Norihiko
机构信息
Department of Internal Medicine, Hematology, Tottori Prefectural Central Hospital, 730 Ezu, Tottori, Tottori, 680-0901, Japan.
出版信息
Int J Hematol. 2011 Sep;94(3):221. doi: 10.1007/s12185-011-0913-9. Epub 2011 Aug 23.
PMID:21861100
Abstract
摘要
相似文献
1
Successful bone reconstruction after bortezomib therapy in a myeloma patient.
Int J Hematol. 2011 Sep;94(3):221. doi: 10.1007/s12185-011-0913-9. Epub 2011 Aug 23.
2
A longitudinal computed tomography study of lenalidomide and bortezomib treatment for multiple myeloma: trabecular microarchitecture and biomechanics assessed using multidetector computed tomography.
Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):485-92. doi: 10.1016/j.clml.2014.07.009. Epub 2014 Aug 12.
3
Bortezomib alone or in combination with the histone deacetylase inhibitor JNJ-26481585: effect on myeloma bone disease in the 5T2MM murine model of myeloma.
Cancer Res. 2009 Jul 1;69(13):5307-11. doi: 10.1158/0008-5472.CAN-08-4472. Epub 2009 Jun 16.
4
Myeloma: diagnosis complications and supportive care.
Hematology. 2012 Apr;17 Suppl 1:S109-11. doi: 10.1179/102453312X13336169156177.
5
Successful use of bortezomib in a patient with systemic lupus erythematosus and multiple myeloma.
Ann Rheum Dis. 2011 Jul;70(7):1344-5. doi: 10.1136/ard.2010.133256. Epub 2010 Dec 20.
6
Effects of bortezomib on bone disease in multiple myeloma.
Am J Hematol. 2009 Jan;84(1):1-2. doi: 10.1002/ajh.21324.
7
Bortezomib-induced acute pancreatitis in a patient with multiple myeloma.
Leuk Lymphoma. 2014 Jun;55(6):1404-5. doi: 10.3109/10428194.2013.831850. Epub 2013 Aug 28.
8
Interstitial pneumonitis caused by Pneumocystis jirovecii pneumonia (PCP) during bortezomib treatment.
Histopathology. 2009 Apr;54(5):631-3. doi: 10.1111/j.1365-2559.2009.03263.x.
9
Efficacy of bortezomib in systemic extramedullary localizations of multiple myeloma.
Clin Adv Hematol Oncol. 2012 Apr;10(4):266-8.
10
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease.
Ann Hematol. 2010 Aug;89(8):821-2. doi: 10.1007/s00277-009-0867-7. Epub 2009 Dec 2.
Zotero 插件